Navigation Links
"Super Drug" Targets Disease-Causing Gene

Researchers at the University of New South Wales in Australia have developed a "super drug" which could one day combat diverse diseases like diabetes//, heart disease, arthritis and cancer. The drug, Dz13, can be used to treat vision loss caused by aging as well, the researchers claimed. Also diseases like heart attacks and inflammation can be contained, they said in a paper published in the latest issue of the journal, Nature Biotechnology. "Our experimental drug Dz13 is like a secret agent that finds its target, c-Jun, within the cell and destroys it," said lead researcher Levon Khachigian, a molecular biologist. The drug works by turning off a disease-causing gene called c-Jun, which is found in diseased blood vessels, eyes, lungs, joints and in the gut. The researchers said animal trials had shown great results. "We're talking about a therapy but whether or not it's a cure remains to be seen," Prof Khachigian said. The drug will be tested at a skin cancer clinical trial next year. Speaking about the research, Professor Bernard Stewart, head of the cancer control program at South Eastern Sydney and Illawarra Health Service said it was a milestone. "It's simple to design drugs on paper that will stop any one of the tens, if not hundreds, of genes that are known to be wrong in cancer," Prof Stewart said. He added that if the drug works in the skin cancer trial, it would be a boon for cancer sufferers, "Conventional chemotherapy works but at a very grim cost in respect of quality of life," Prof Stewart said.
'"/>




Page: 1

Related medicine news :

1. Research Targets treatment for dementia and brain injuries
2. Cancer Treatments Fall Short Of Targets
3. India Targets Eliminating Leprosy
4. Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome
5. Health Targets To Treat Cancer Patients Unlikely To Be Met
6. Queensland Government to Meet its Medical Targets
7. No Clear Evidence for Ultra-Low Cholesterol Targets?
8. Health Minister Stresses the Importance of Realistic Health Targets
9. NIDs Targets Immunizations To 22 Million Children In Bangladesh
10. Researchers Identify New Drug Targets for Cancer
11. VBI Provides Potential Targets to Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing ... acute or chronic problems, I focus on preventative care with all my patients to alleviate ... any questions, always feel free to contact my office and my trained staff will assist ...
(Date:4/25/2017)... ... 2017 , ... Amendia, Inc., designer, developer, and manufacturer of ... and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization dedicated to ... spine deformity cases, particularly in children. , GSO’s focus is to provide hands-on ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
(Date:4/24/2017)... ... April 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer ... to 1,961 people during the April 22-23 event at the San Mateo Event Center. ... experience barriers to care, CDA Cares educates the public and policymakers about the importance ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 /PRNewswire/ ... ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron Ehlen ... the signing of a three-year exclusive sales representation ... a dedicated sales team to introduce Imprimis, ophthalmic ... focused in 13 states in the U.S. Midwest. Precision ...
Breaking Medicine Technology: